OMDA
Omada Health
OMDA lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
OMDA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Strong |
OMDA's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
OMDA PE Valuation
OMDA has no meaningful PE right now: it lost money over the past year.
OMDA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OMDA, with profitability improving.
OMDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.50 | — |
| Q3 2025 | -$0.62 | +$0.33 |
| Q2 2025 | -$0.73 | +$0.30 |
OMDA is still losing money, but less than at its worst: $0.62 per share over the past year, against $1.03 at its worst in mid-2024.
OMDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $91.3M | +34% |
| Q2 2026 | $87.8M | +43% |
| Q1 2026 | $78M | +42% |
| Q4 2025 | $75.8M | +58% |
| Q3 2025 | $68M | +49% |
| Q2 2025 | $61.4M | +49% |
| Q1 2025 | $55M | +57% |
| Q4 2024 | $48M | +47% |
OMDA's revenue has grown year over year every quarter since late 2024: $91M last quarter, up 34% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.3% | +9 points |
| Q2 2026 | 4% | +11 points |
| Q1 2026 | -6.1% | +9.1 points |
| Q4 2025 | 4.3% | +19 points |
| Q3 2025 | -3.7% | +15 points |
| Q2 2025 | -7.1% | +17 points |
| Q1 2025 | -15% | +36 points |
| Q4 2024 | -15% | +26 points |
OMDA's operating margin was 5.3% last quarter, up 9 points from the same quarter a year ago, near the top of its range since 2023.
OMDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $15M | +57% |
| Q1 2026 | -$11.9M | +$5.5M |
| Q4 2025 | $21.2M | +$28.6M |
| Q3 2025 | $9.6M | +$9.6M |
| Q1 2025 | -$17.4M | +$4.1M |
OMDA's free cash flow has turned positive after two years mostly in the red: $28M over the past year.
OMDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5% | +3.2M shares |
| 1 year | +205% | +45.1M shares |
OMDA has 67M diluted shares, up 205% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
OMDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -18.6x | Net Cash |
| Q2 2026 | -40.8x | Net Cash |
OMDA has more cash than debt.
OMDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.4 | Neutral |
| Stochastic | 7.4 | Oversold |
OMDA's weekly RSI is 37 (neutral) and its Stochastic is 7 (oversold).
OMDA PE vs Healthcare Sector
OMDA has no meaningful PE right now: it lost money over the past year.
OMDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.3 | 20% below |
| 20 week MA | $20.7 | 29% below |
| 50 week MA | $17.3 | 15% below |
OMDA is in a downtrend: it's below all three of its weekly moving averages, and 15% below its 50-week average.
OMDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $23.0 | $16.0 | -31% |
| 2026 YTD | $16.0 | $14.7 | -7.8% |
OMDA has finished every year since 2025 lower, and it's down 7.8% so far in 2026.